Abstract:Main text(Molecular Therapy 26, 2466–2475, October 2018)Molecular Therapy is retracting this article. After investigating concerns of image duplication raised by a reader, evidence for image duplication in identical or altered fashion in Figures 4A, 4G, and S1C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. Main text(Molecular Therapy 26, 2466–2475, October 2018)Molecular Therapy is retracting this article. After investigating concerns of image duplication raised by a reader, evidence for image duplication in identical or altered fashion in Figures 4A, 4G, and S1C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. (Molecular Therapy 26, 2466–2475, October 2018) Molecular Therapy is retracting this article. After investigating concerns of image duplication raised by a reader, evidence for image duplication in identical or altered fashion in Figures 4A, 4G, and S1C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. RETRACTED: Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial CellsYang et al.Molecular TherapyAugust 3, 2018In BriefThis article has been retracted: please see Elsevier Policy on Article Withdrawal ( http://www.elsevier.com/locate/withdrawalpolicy ). Full-Text PDF Open Archive

RETRACTED: Exosome-Derived Mir-130A Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells

Retraction Notice To: Exosome-Derived Mir-130A Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells

RETRACTED: Mir-135B Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis

Retraction Notice to: Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells

Retraction Notice To: Tumor Cell-Secreted Exosomal Mir-22-3p Inhibits Transgelin and Induces Vascular Abnormalization to Promote Tumor Budding

Retraction: Epigenetic Silencing Of Mir-130a Ameliorates Hemangioma By Targeting Tissue Factor Pathway Inhibitor 2 Through Fak/Pi3k/Rac1/Mdm2 Signaling (Retraction Of Vol 50, Pg 1821, 2017)

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]

RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

Retraction Note: Decreased Expression of Mir-939 Contributes to Chemoresistance and Metastasis of Gastric Cancer Via Dysregulation of SLC34A2 and Raf/MEK/ERK Pathway

Retraction Note: Microrna-15B-5p Encapsulated by M2 Macrophage-Derived Extracellular Vesicles Promotes Gastric Cancer Metastasis by Targeting BRMS1 and Suppressing DAPK1 Transcription

RETRACTED: A Novel Circular RNA Circ-Znf652 Promotes Hepatocellular Carcinoma Metastasis Through Inducing Snail-Mediated Epithelial-Mesenchymal Transition by Sponging Mir-203/Mir-502-5p.

[Retracted] Exosomal Mir‑130a‑3p Promotes the Progression of Differentiated Thyroid Cancer by Targeting Insulin‑like Growth Factor 1

RETRACTED: MiR-650 Regulates the Proliferation, Migration and Invasion of Human Oral Cancer by Targeting Growth Factor Independent 1 (Gfi1).

Retracted: MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).

RETRACTED: Neferine Inhibits Proliferation, Migration and Invasion of U251 Glioma Cells by Down-Regulation of Mir-10B.

RETRACTION: MicroRNA-454 inhibits the malignant biological behaviours of gastric cancer cells by directly targeting mitogen-activated protein kinase 1 (Retraction of Vol 39, Pg 1494, 2018)

Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging

Retraction Note: M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade

RETRACTION: miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer (Retraction of Vol 234, Pg 23596, 2020)

RETRACTED: EMP3, Which is Regulated by Mir-663A, Suppresses Gallbladder Cancer Progression Via Interference with the MAPK/ERK Pathway.